Key result
Nipradilol significantly reduced ST segment depression relative to heart rate increase during exercise compared to propranolol (5.57 vs 6.71 µV/bpm, p<0.05).
Why the study?
Does nipradilol improve exercise-induced ST segment depression relative to heart rate compared to propranolol in patients with stable angina pectoris?
Does nipradilol improve exercise-induced ST segment depression relative to heart rate compared to propranolol in patients with stable angina pectoris?
Nipradilol may have beneficial effects on exercise ECG in angina pectoris beyond its β-blocking action, likely due to its vasoactive properties, as evidenced by improved HR-ST loop dynamics compared to propranolol.
Hypothesis-generating for nipradilol's HR-ST effects in stable angina; leaves open confirmation in outcome trials.
To study the effect of nipradilol, a new antianginal agent with vasoactive property as well as β-blocking action, on exercise electrocardiogram, multi-stage treadmill tests were performed after the administration of nipradilol and propranolol in 10 patients with stable effort angina pectoris. The effect of nipradilol on conventional measures in exercise ECG (heart rate, systolic BP, ST segment deviation, exercise duration, pressure rate product) was not significantly different from that of propranolol. An analysis of heart rate-ST loop (HR-ST loop), ST segment deviation plotted as a function of heart rate, during exercise and recovery revealed that nipradilol shifted the HR-ST loop rightward, indicating less prominent ST segment depression relative to the increase in HR when compared with propranolol. Calculated ST segment depression relative to the change in HR was smaller with nipradilol than with propranolol during exercise (ΔST/ΔHR from rest to peak exercise: nipradilol 5.57±0.81 vs propranolol 6.71±1.07μV/bpm, p<0.05) and recovery (recovery index: nipradilol 1.83±0.65 vs propranolol 3.01± 0.74μV/bpm, p<0.05). These results indicated that nipradilol may have beneficial effects on exercise ECG in angina pectoris other than β-blocking action, such as a vasoactive property.
No takes yet. Share an insight, caveat, or question.
Tsunakawa et al. (1995) studied Stable effort angina pectoris (n=10). Nipradilol vs. Propranolol was evaluated on ΔST/ΔHR from rest to peak exercise (µV/bpm) (p=<0.05). Nipradilol significantly reduced ST segment depression relative to heart rate increase during exercise compared to propranolol (5.57 vs 6.71 µV/bpm, p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: